Data from the GEPIA 2 database [139] indicate that Gal-1 expression is significantly decreased in six tumor types, increased in ten, and shows no significant changes in another seventeen tumor types compared to normal samples (Fig. 5). The gene discussed is LGALS1; the disease is neoplasm.